Radboud University Medical Center, Department of Psychiatry, Center for Mindfulness, Nijmegen, the Netherlands.
University of Twente, Department of Psychology, Health, and Technology, Center for eHealth and Well-being Research, Enschede, the Netherlands.
J Affect Disord. 2024 Sep 1;360:79-87. doi: 10.1016/j.jad.2024.05.110. Epub 2024 May 22.
This study aimed to identify moderators of treatment effect (i.e. depressive symptoms and well-being) of Mindfulness-Based Cognitive Therapy (MBCT) and Positive Psychology Intervention (PPI) in patients with bipolar disorder.
Data were drawn from two multicenter randomized controlled trials investigating effectiveness of MBCT vs treatment as usual (TAU; n = 144) and PPI vs TAU (n = 97) in bipolar disorder. Outcomes were assessed at baseline, posttreatment, and 12 months after baseline. Data were analyzed using separate linear regression models, comparing the pooled MBCT or PPI outcomes to TAU, and comparing MBCT to PPI.
The exploratory analyses not corrected for multiple comparisons showed a number of variables that were associated with stronger response to the interventions, including higher baseline anxiety, lower well-being, and lower levels of self-focused positive rumination, well-being, and self-compassion, and variables associated with a stronger response to either MBCT (higher levels of depression and anxiety and being married) or PPI (being male). After correcting for multiple testing, depressive symptoms appeared to be the most robust variable associated with better response to MBCT than PPI.
The RCTs handled slightly different enrollment criteria and outcome measures.
The most robust finding is that patients with more severe symptomatology seem to benefit more from MBCT than PPI.
This is a first step to improve personalized assignment of third-wave CBT interventions for patients with bipolar disorder. However, before definite treatment assignment criteria can be formulated and implemented in clinical practice, these findings should be replicated.
本研究旨在确定正念认知疗法(MBCT)和积极心理干预(PPI)治疗双相障碍患者的疗效(即抑郁症状和幸福感)的调节因素。
数据来自两项多中心随机对照试验,分别调查 MBCT 与常规治疗(TAU;n=144)和 PPI 与 TAU(n=97)治疗双相障碍的有效性。结局在基线、治疗后和基线后 12 个月进行评估。采用单独的线性回归模型进行分析,将 pooled MBCT 或 PPI 结局与 TAU 进行比较,并将 MBCT 与 PPI 进行比较。
未经多重比较校正的探索性分析显示,许多变量与干预反应更强相关,包括基线时更高的焦虑、更低的幸福感、更低的自我聚焦积极反刍、幸福感和自我同情水平,以及与 MBCT(更高水平的抑郁和焦虑和已婚)或 PPI(男性)反应更强相关的变量。在进行多重检验校正后,抑郁症状似乎是与 MBCT 反应优于 PPI 最相关的变量。
RCT 处理了略有不同的入组标准和结局指标。
最有力的发现是,症状更严重的患者似乎从 MBCT 中获益多于 PPI。
这是为改善双相障碍患者的第三波 CBT 干预措施的个性化分配迈出的第一步。然而,在明确制定和实施临床实践中的治疗分配标准之前,这些发现需要得到复制。